Medical Properties Trust (MPW) Receiving Somewhat Favorable News Coverage, Analysis Shows
News headlines about Medical Properties Trust (NYSE:MPW) have been trending somewhat positive on Wednesday, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Medical Properties Trust earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave media headlines about the real estate investment trust an impact score of 45.7446825375909 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Here are some of the news stories that may have effected Accern’s analysis:
- Jefferies Group Analysts Cut Earnings Estimates for Medical Properties Trust, Inc. (MPW) (americanbankingnews.com)
- Medical Properties Trust, Inc. Expected to Post FY2017 Earnings of $1.37 Per Share (MPW) (americanbankingnews.com)
- Brokerages Anticipate Medical Properties Trust, Inc. (MPW) Will Announce Quarterly Sales of $196.73 Million (americanbankingnews.com)
- Medical Properties Trust, Inc. (MPW) Receives Average Recommendation of “Hold” from Brokerages (americanbankingnews.com)
- FY2018 Earnings Forecast for Medical Properties Trust, Inc. Issued By KeyCorp (MPW) (americanbankingnews.com)
Medical Properties Trust (MPW) traded up $0.21 during trading hours on Wednesday, reaching $13.03. The company’s stock had a trading volume of 1,961,039 shares, compared to its average volume of 2,300,000. The company has a current ratio of 2.55, a quick ratio of 2.55 and a debt-to-equity ratio of 1.26. The company has a market capitalization of $4,740.00, a PE ratio of 17.14, a PEG ratio of 1.56 and a beta of 0.96. Medical Properties Trust has a twelve month low of $11.90 and a twelve month high of $14.22.
Medical Properties Trust (NYSE:MPW) last posted its quarterly earnings results on Thursday, November 2nd. The real estate investment trust reported $0.33 EPS for the quarter, beating the Zacks’ consensus estimate of $0.32 by $0.01. The business had revenue of $176.60 million for the quarter, compared to analysts’ expectations of $172.57 million. Medical Properties Trust had a return on equity of 7.36% and a net margin of 39.95%. The business’s quarterly revenue was up 39.5% on a year-over-year basis. During the same period last year, the firm earned $0.30 earnings per share. research analysts forecast that Medical Properties Trust will post 1.33 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Thursday, January 11th. Stockholders of record on Thursday, December 7th were given a dividend of $0.24 per share. The ex-dividend date of this dividend was Wednesday, December 6th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 7.37%. Medical Properties Trust’s payout ratio is 126.32%.
MPW has been the topic of a number of recent research reports. ValuEngine raised Medical Properties Trust from a “hold” rating to a “buy” rating in a report on Monday, October 2nd. SunTrust Banks reissued a “buy” rating and set a $15.00 price target on shares of Medical Properties Trust in a report on Friday, November 3rd. Robert W. Baird cut Medical Properties Trust from an “outperform” rating to a “neutral” rating and decreased their price target for the company from $15.00 to $13.00 in a report on Friday, January 5th. JPMorgan Chase & Co. raised Medical Properties Trust from an “underweight” rating to a “neutral” rating and set a $14.50 price target on the stock in a report on Friday, December 15th. Finally, Zacks Investment Research raised Medical Properties Trust from a “sell” rating to a “hold” rating in a report on Tuesday. Eight investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Medical Properties Trust currently has an average rating of “Hold” and a consensus target price of $14.30.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.